|[April 02, 2014]
Research and Markets: US Blood Typing, Grouping and Infectious Disease Screening Market 2014-2019: Sales Forecasts, Supplier Shares, Competitive Strategies
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/k5w76k/us_blood_typing)
has announced the addition of the "US
Blood Typing, Grouping and Infectious Disease Screening Market 2014:
Sales Forecasts, Supplier Shares, Competitive Strategies"
report to their offering.
During the next five years, the US blood banking market is expected to
undergo significant transformation, which will result from the
convergence of several trends, including more stringent regulations
advances in diagnostic technologies, IT, system engineering and
automation and intensifying competition. Some segments will start
resembling commodity markets, where product positioning and
differentiation are more critical than underlying technology.
The changes in the marketplace will create exciting opportunities for
new instruments and reagent systems, as well as auxiliary products, such
as specimen preparation devices, controls, calibrators, and innovative
New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
The report explores future marketing and technological trends in the US
provides estimates of the test volume, instrument placements and sales
compares features of major automated and semi-automated analyzers
profiles leading and emerging competitors and identifies specific
product and market opportunities facing suppliers during the next ten
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P,
S, s), Antiglobulin (Direct, C3 (News - Alert) + IgG, IgG, C3), Crossmatching
(Immediate Spin, Full Crossmatch), Rh (D, Du).
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT,
HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19
NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates of leading suppliers of blood banking
of reagents and instruments, by individual product.
Strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, and new
products in R&D.
Market Segmentation Analysis
Comprehensive market segmentation analysis, including review of the
market dynamics, trends, structure, size, growth, and key suppliers.
Test volume and sales forecasts for over 40 blood banking tests,
including NAT, by market segment:
Plasma Fractionation Facilities
Military Blood Banks
Current and Emerging Products
Analysis of current and emerging blood banking tests.
Review of automated and semi-automated analyzers, including their
operating characteristics, features, and selling prices.
Assessment of current and emerging technologies, and their potential
applications for the blood banking market.
Comprehensive lists of companies developing or marketing new
technologies and products by test.
For more information visit http://www.researchandmarkets.com/research/k5w76k/us_blood_typing
[ Back To TMCnet.com's Homepage ]